MedTrace Logo

Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion

NCT01676740 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2012-09-03

No results posted yet for this study

Summary

To establish the efficacy of screening for anemia and treatment of mild anemia with iron and vitamins prior to THR and TKR as a means of increasing hemoglobin and reducing perioperative allogeneic blood transfusion.

Conditions

  • Excessive Amount of Blood / Fluid Transfusion

Interventions

DRUG

Iron Supplement,

Pills to be swallowed

DRUG

Placebo

Daily administration of active drug or placebo

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Martin H Ellis, MD · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2013-12-31
Completion
2014-02-28

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01676740 on ClinicalTrials.gov